WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › OCUL

Which hedge funds own OCUL? OCULAR THERAPEUTIX INC, Q2 2026 13F holders

Healthcare · Open on the interactive board

8 of the hedge funds tracked by WhaleCreep disclosed a position in OCUL (OCULAR THERAPEUTIX INC) in their Q2 2026 13F filings, worth $63.3m in total. The largest holder by portfolio weight is Woodline Partners at 0.1% of its book. 2 exited: Farallon Capital Management, Millennium Management.

8tracked managers holding
0opened this quarter
2exited this quarter

Which hedge funds hold OCUL? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Woodline PartnersQ2 2026 0.1%$16.4m1,667,609 0% held
Point72 Asset Management LPQ2 2026 0.0%$32.3m3,292,193 -41% reduced
Tudor InvestmentQ2 2026 0.0%$5.1m522,663 -15% reduced
Renaissance Technologies LLCQ2 2026 0.0%$3.7m378,754 -67% reduced
Brevan Howard Capital ManagementQ2 2026 0.0%$242.2k24,659 101% added
Citadel AdvisorsQ2 2026 0.0%$3.0m310,484 -51% reduced
Marshall WaceQ2 2026 0.0%$1.2m126,033 -83% reduced
D. E. Shaw & CoQ2 2026 0.0%$1.2m124,457 -43% reduced

Exited since the previous quarter

ManagerPrior weightPrior value
Farallon Capital Management0.0%$152.5k
Millennium Management0.0%$288.0k

How has hedge fund ownership of OCUL changed?

QuarterManagers holdingCombined value
Q2 20268$63.3m
Q1 202610$90.0m
Q4 20255$48.4m
Q3 20253$75.2m
Q2 20253$28.4m
Q1 20254$23.7m
Q4 20242$33.6m
Q3 20242$26.5m
Q2 20241$18.5m
Q1 20242$948.2k
Q4 20231$618.7k
Q3 20232$939.9k
Q2 20232$1.2m
Q1 20232$735.0k
Q4 20222$1.1m
Q3 20223$321.0k

Counts every tracked manager that disclosed OCUL in that quarter's filing, including managers that have since stopped filing.